Chemoselective Radical Dehalogenation and C–C Bond Formation on Aryl Halide Substrates Using Organic Photoredox Catalysts von Poelma, Saemi O, Burnett, G. Leslie, Discekici, Emre H, Mattson, Kaila M, Treat, Nicolas J, Luo, Yingdong, Hudson, Zachary M, Shankel, Shelby L, Clark, Paul G, Kramer, John W, Hawker, Craig J, Read de Alaniz, Javier

Volltext

Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growth von Lee, Bianca J., Boyer, Jacob A., Burnett, G. Leslie, Thottumkara, Arun P., Tibrewal, Nidhi, Wilson, Stacy L., Hsieh, Tientien, Marquez, Abby, Lorenzana, Edward G., Evans, James W., Hulea, Laura, Kiss, Gert, Liu, Hui, Lee, Dong, Larsson, Ola, McLaughlan, Shannon, Topisirovic, Ivan, Wang, Zhengping, Wang, Zhican, Zhao, Yongyuan, Wildes, David, Aggen, James B., Singh, Mallika, Gill, Adrian L., Smith, Jacqueline A. M., Rosen, Neal

Volltext

Author Correction: Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growth von Lee, Bianca J., Boyer, Jacob A., Burnett, G. Leslie, Thottumkara, Arun P., Tibrewal, Nidhi, Wilson, Stacy L., Hsieh, Tientien, Marquez, Abby, Lorenzana, Edward G., Evans, James W., Hulea, Laura, Kiss, Gert, Liu, Hui, Lee, Dong, Larsson, Ola, McLaughlan, Shannon, Topisirovic, Ivan, Wang, Zhengping, Wang, Zhican, Zhao, Yongyuan, Wildes, David, Aggen, James B., Singh, Mallika, Gill, Adrian L., Smith, Jacqueline A. M., Rosen, Neal

Volltext

Author Correction: Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growth von Lee, Bianca J., Boyer, Jacob A., Burnett, G. Leslie, Thottumkara, Arun P., Tibrewal, Nidhi, Wilson, Stacy L., Hsieh, Tientien, Marquez, Abby, Lorenzana, Edward G., Evans, James W., Hulea, Laura, Kiss, Gert, Liu, Hui, Lee, Dong, Larsson, Ola, McLaughlan, Shannon, Topisirovic, Ivan, Wang, Zhengping, Wang, Zhican, Zhao, Yongyuan, Wildes, David, Aggen, James B., Singh, Mallika, Gill, Adrian L., Smith, Jacqueline A. M., Rosen, Neal

Volltext

New strategies for natural products containing chroman spiroketals von Green, Jason C., Burnett, G. Leslie, Pettus, Thomas R. R.

Volltext

Controlled drug release to cancer cells from modular one-photon visible light-responsive micellar system von Poelma, Saemi O, Oh, Seung Soo, Helmy, Sameh, Knight, Abigail S, Burnett, G Leslie, Soh, H Tom, Hawker, Craig J, Read de Alaniz, Javier

Volltext

Synthesis of Hindered α‑Amino Carbonyls: Copper-Catalyzed Radical Addition with Nitroso Compounds von Fisher, David J, Burnett, G. Leslie, Velasco, Rocío, Read de Alaniz, Javier

Volltext

A Strategy for the Late-Stage Divergent Syntheses of Scyphostatin Analogues von Cha, Jacob Y, Burnett, G. Leslie, Huang, Yaodong, Davidson, Jarrod B, Pettus, Thomas R. R

Volltext

Discovery of RMC-5552, a Selective Bi-Steric Inhibitor of mTORC1, for the Treatment of mTORC1-Activated Tumors von Burnett, G. Leslie, Yang, Yu C., Aggen, James B., Pitzen, Jennifer, Gliedt, Micah K., Semko, Chris M., Marquez, Abby, Evans, James W., Wang, Gang, Won, Walter S., Tomlinson, Aidan C. A., Kiss, Gert, Tzitzilonis, Christos, Thottumkara, Arun P., Cregg, James, Mellem, Kevin T., Choi, Jong S., Lee, Julie C., Zhao, Yongyuan, Lee, Bianca J., Meyerowitz, Justin G., Knox, John E., Jiang, Jingjing, Wang, Zhican, Wildes, David, Wang, Zhengping, Singh, Mallika, Smith, Jacqueline A. M., Gill, Adrian L.

Volltext

Abstract ND10: Discovery of RMC-5552: A selective bi-steric inhibitor of mTORC1 that suppresses 4EBP1 phosphorylation, for the treatment of mTORC1-activated tumors including RAS pa... von Burnett, G. Leslie

Volltext

Determination of methylene bridge crosslinking in chloromethylated PS‐DVB resins von Burnett, G. Leslie, Rohanna, John C., Rosenberg, Steve, Schultz, Alfred K., Read de Alaniz, Javier

Volltext

Abstract B108: 4EBP3 mRNA as a biomarker of therapeutic response to treatment with mTORC1 inhibitors von Lee, Bianca J., Dinglasan, Nuntana, Nguyen, Tram, Lorenzana, Ed, Wilson, Stacy, Burnett, G. Leslie, Aggen, James B., Nichols, Robert J., Singh, Mallika, Wildes, David, Smith, Jaqueline A.M.

Volltext

Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growth (vol 17, pg 1065, 2021) von Lee, BJ, Boyer, JA, Burnett, GL, Thottumkara, AP, Tibrewal, N, Wilson, SL, Hsieh, T, Marquez, A, Lorenzana, EG, Evans, JW

Volltext

Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growth (Jun, 10.1038/s41589-021-00813-7, 2021) von Lee, Bianca J., Boyer, Jacob A., Burnett, G. Leslie, Thottumkara, Arun P., Tibrewal, Nidhi, Wilson, Stacy L., Hsieh, Tientien, Marquez, Abby, Lorenzana, Edward G., Evans, James W., Hulea, Laura, Kiss, Gert, Liu, Hui, Lee, Dong, Larsson, Ola, McLaughlan, Shannon, Topisirovic, Ivan, Wang, Zhengping, Wang, Zhican, Zhao, Yongyuan, Wildes, David, Aggen, James B., Singh, Mallika, Gill, Adrian L., Smith, Jacqueline A. M., Rosen, Neal

Volltext

Abstract PR04: 4EBP1 reactivation by potent and selective bi-steric inhibitors of mTORC1 von Tibrewal, Nidhi, Aggen, James B., Bassan, Abraham I., Burnett, G. Leslie, Evans, Jim, Gliedt, Micah J., Hsieh, Daphne, Kiss, Gert, Lee, Bianca J., Lee, Dong, Lorenzana, Ed, Marquez, Abby, Thottumkara, Arun, Wang, Zhengping, Wilson, Stacy, Zhao, Frances, Goldsmith, Mark, Singh, Mallika, Wildes, Pete, Gill, Adrian L., Smith, Jacqueline A.M.

Volltext

Controlled drug release to cancer cells from modular one-photon visible light-responsive micellar systemElectronic supplementary information (ESI) available. See DOI: 10.1039/c6cc0... von Poelma, Saemi O, Oh, Seung Soo, Helmy, Sameh, Knight, Abigail S, Burnett, G. Leslie, Soh, H. Tom, Hawker, Craig J, Read de Alaniz, Javier

Volltext

Abstract LB015: Bi-steric mTORC1-selective inhibitors activate 4EBP1, suppress MYC, restore anti-tumor immunity, and cooperate with immune checkpoint inhibition to elicit tumor reg... von Mahauad-Fernandez, Wadie D., Yang, Yu Chi, Lai, Ian, Park, Jangho, Yao, Lilian, Evans, James W., Atibalentja, Danielle F., Chen, Xinyu, Zhao, Zihui, Burnett, G. Leslie, Lee, Bianca J., Dinglasan, Nuntana, Shifrin, Nataliya, Ahler, Ethan, Quintana, Elsa, Gill, Adrian, Smith, Jacqueline A., Singh, Mallika, Felsher, Dean W.

Volltext

Abstract 3596: RM-036, a first-in-class, orally-bioavailable, Tri-Complex covalent KRASG12D(ON) inhibitor, drives profound anti-tumor activity in KRASG12D mutant tumor models von Knox, John E., Jiang, Jingjing, Burnett, G. Leslie, Liu, Yang, Weller, Caroline E., Wang, Zhican, McDowell, Laura, Steele, Shelby L., Chin, Shook, Chou, Kang Jye, Wang, Fang, Zhong, Mengqi, Koltun, Elena S., Wildes, David, Singh, Mallika, Gill, Adrian L., Smith, Jacqueline A.

Volltext

C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors von Pitzen, Jennifer, Burnett, G. Leslie, Aggen, James Bradley

Volltext bestellen

RAS INHIBITORS von LIU, Yang, CREGG, James, GILL, Adrian L, KOLTUN, Elena S, KNOX, John E, BURNETT, G. Leslie

Volltext bestellen